OCBCO
CYTK icon

Oversea-Chinese Banking Corp (OCBC)’s Cytokinetics CYTK Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,057
Closed -$323K – 335
2022
Q4 		$323K Buy
+7,057
New +$304K 0.02% 275

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s CYTK Position: Q1 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Cytokinetics (CYTK) in Q1 2023, closing a stake of 7,057 shares — an estimated $323K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in CYTK in Q4 2022 and held it in 1 quarter. The position peaked at $323K in Q4 2022. 262 funds tracked by Wall St. Rank hold CYTK as of Q1 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining Cytokinetics position as of Q1 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 7,057 Cytokinetics shares in Q1 2023, an estimated $323K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Cytokinetics in Q4 2022 and held it in 1 quarter.
  • Oversea-Chinese Banking Corp (OCBC)'s Cytokinetics position peaked at $323K in Q4 2022.
  • 262 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2023, filed 4 May 2023.